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The purpose of this paper was to check if viable bacteria, in particular lactic acid bacteria (LAB), could be enriched from biopsies
obtained from healthy gastroscopy patients. Gastric biopsies were obtained from 13 gastroscopy patients and subjected to an
anaerobic or microaerophilic enrichment procedure utilizing the Portable Microbe Enrichment Unit (PMEU). Profuse microbial
growthwasobservedinmostcases.SamplesplatedonMRSshowedhighnumbersofLAB.Themostcommonspeciescharacterized
wereLactobacillusreuteri,Lact.salivarius,andStreptococcussalivarius.TheresultsdemonstrateacontinuouspresenceofviableLAB
in healthy stomach. The species are similar to those traditionally used in food applications. The gastric LAB strains could have a
potential in developing probiotic foods aimed specially on the upper part of the gastrointestinal tract.
1.Introduction
Although a diverse bacterial biota has been detected in the
human esophagus [1], the human stomach has traditionally
been considered as an almost sterile environment, where
bacterial presence is limited and any bacterial growth is a
result of pathological conditions such as Helicobacter pylori
infection or as a result of acid-suppressive therapy [2–4].
While the bacterial densities in stomach undoubtedly
are considerably lower than those detected in the ileum
and colon, the possibility of acid-tolerant bacteria being
continuously present on the gastric mucosal surfaces cannot
be excluded. Lactic acid bacteria (LAB) are particularly
interesting in this respect, because of the demonstrated
positive health eﬀects of certain LAB strains as probiotic
microorganisms [5, 6]. The ability to survive and transiently
colonize the gastrointestinal tract has been considered as
one of the selection criteria for eﬃcient probiotics [7], the
acidicenvironmentofthestomachbeingoneofthehurdlesa
probioticbacteriumfacesduringthegastrointestinalpassage.
The duodenal conditions with relatively high concentrations
of bile substances favor a typical ﬂora almost devoid of LAB




2.1. Gastroscopies. Altogether, thirteen subjects were rec-
ruited for the study among patients coming to normal
diagnostic gastroscopy. The subjects had a normal Western
diet and did not receive any medication that might interfere
with gastrointestinal microbiota. Fasting overnight was the
standard routine of the procedure. Biopsies were taken from
the cardial, antrum, and pyloric regions of the stomach.
2.2. Enrichment. The enrichment was done using the PMEU
technology (Portable Microbe Enrichment Unit, Finnoﬂag
Oy and Samplion Oy, Kuopio and Siilinj¨ arvi, Finland,
Figure 1)[ 9]. The biopsies were ﬁrst aseptically immersed
into test tubes containing 1.5mL of thioglycollate medium
(Difco, USA) and mixed carefully in an anaerobic glove
box. Then the contents of the tubes were moved into 20mL
enrichment syringes. The syringes were containing 10mL of
fastidious anaerobe broth (Lab M, UK).2 ISRN Gastroenterology
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Cardia Antrum Pylorus
Plate














1 Anaerobic 8.9 9.0 8.0 8.5 8.7 8.1 8.5 8.7 8.0
2 Anaerobic 8.3 8.1 7.0 <5.0 5.3 <5.0 <5.0 <5.0 <5.0
3 Anaerobic 8.2 8.3 <5.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0
4 Anaerobic 9.2 8.3 5.9 8.9 7.5 <5.0 <1.0 <1.0 <1.0
5 Microaerophilic 8.0 8.4 7.6 8.2 8.3 6.6 8.2 8.2 6.6
6 Microaerophilic 8.0 8.0 8.0 8.4 8.1 7.1 8.5 8.5 8.1
7 Microaerophilic 8.5 8.0 8.5 8.4 8.3 8.3 7.8 8.5 8.4
8 Microaerophilic 8.6 8.8 4.7 8.5 8.6 5.3 8.5 8.5 6.9
9 Microaerophilic 8.1 8.1 8.1 <1.0 5.8 <1.0 8.3 8.1 5.8
10 Microaerophilic 8.6 8.1 8.0 7.8 8.0 5.7 8.4 8.4 6.6
11 Microaerophilic 6.1 6.0 <5.0 8.1 8.5 6.4 8.0 7.6 <5.0
12b Microaerophilic 9.3 8.6 ndc 8.3 8.3 nd 7.9 8.0 nd
13b Microaerophilic <2.0 6.2 nd 6.6 6.6 nt 6.3 6.4 nd
a< in front of the log means values below the detection limit in the particular experiment.
bThe plating and incubation of these samples were done in aerobic conditions.
cnd = not done.
Figure 1: Portable Microbe Enrichment Unit (Samplion Oy).
In the present experiment the PMEU unit was adjusted
to either anaerobic or microaerobic cultivation mode using
continuous gas ﬂow into the medium. The anaerobic gas
mixtureconsistedof80%N2,10%CO2,and10%H2 whereas
the composition of the microaerobic gas ﬂow was 5% O2,
10% CO2, and 85% N2. The pre-enrichment periods varied
b e t w e e n2 2a n d2 3 . 5( f o ra n a e r o b i cc u l t u r e s ) ,a n db e t w e e n
23.5 and 24 hours (for microaerobic cultures) at 37◦C.
Thecultivablebacterialcountsafterpre-enrichmentwere
studied by plating dilution series of the enrichment onto
Petri dishes and cultivating them anaerobically at 37◦Co n
Man-Rogosa Sharpe (MRS; Lab M, UK) agar (for lactic
acid bacteria 72h), on Plate Count (PC; Lab M, UK) agar
(48h), and on Wilkins Chalgren (Oxoid, UK) agar (for
the Bacteroides group and other anaerobes, 72h). Some
samples were also used for plating onto MRS and PC agar
without pre-enrichment and incubated both anaerobically
andaerobically,theincubationtimesandtemperaturesbeing
the same as in the platings from enrichment cultures.
2.3. The Characterization of LAB. The cells from the most
dominant isolates on the basis of colony morphology on
MRSplateswereGramstainedandobservedmicroscopically.
The Gram-positive rods or cocci were further subjected to
tentative identiﬁcation by API CH50 proﬁling (bioM´ erieux
SA,France),followedby16sDNAsequencing.Totalgenomic
DNA was extracted from biopsy samples by using Charge
Switch gDNA Mini Bacteria Kit (InVitrogen, USA). The
primers used for the ampliﬁcation were the archael 16S
rDNA gene primers 27F (TCCGGTTGATCCTGCCGGAG)
and685R(TTACGGGATTTCACTCCTAC)yieldinga650bp
fragment. PCR ampliﬁcations were performed in a ﬁnal
volume of 50µL reactions using 1µL template DNA, 0,25µM
o fe a c hp r i m e r ,e a c hd N T Pa t0 , 2 m M ,1 , 5 m MM g C l 2,1 x
PCR buﬀer, and 1U Go Taq Polymerase (Promega, USA).
DNA was ampliﬁed for 40 cycles of 40s at 94◦C, 90s at 56◦C,
and 40s at 72◦C followed by 10min at 72◦C. The ampliﬁed
products were detected on 1% agarose gel and puriﬁed with
NucleoSpin ExtractII kit (Macherey-Nagel, Germany). The
PCR products were sequenced by Agova, Germany. The
sequences were compared directly with the EMBL nucleotide
database using the BLAST database sequence search engine.
2.4. Ethical Aspects. The study plan was reviewed and
approved by the Ethical Committee of the Kuopio University
Hospital.ISRN Gastroenterology 3
Table 2: Background values of CFU counts from the enrichment culture before the enrichment step.
Patient number Plating conditions
log CFU mL−1 mediuma
Site of the biopsy
Cardia Antrum Pylorus
Plate count agar MRS agar Plate count agar MRS agar Plate count agar MRS agar
11 Anaerobic 6.1 6.0 5.3 4.2 2.3 3.1
12 Anaerobic 3.0 <2.0 2.8 2.8 3.1 3.3
Aerobic 2.2 <2.0 3.0 3.2 3.5 3.0
13 Anaerobic <2.0 <2.0 <2.0 <2.0 <2.0 <2.0
Aerobic <2.0 <2.0 3.1 <2.0 <2.0 <2.0
a< in front of the log means values below the detection limit in the particular experiment.
Table 3: The identiﬁed LAB species enriched from the biopsies obtained from diﬀerent gastric sites.
Patient number Cardia Antrum Pylorus
1
Ent. faecalis (2)a
Lact. salivarius (2) Lact. salivarius Step. salivarius
Lact. salivarius ssp. salivarius
2 Strep. salivarius (2)
4
Strep. sanguinis (2)
Strep. salivarius Strep. salivarius
Ent. faecalis
5 Strep. salivarius Strep. salivarius Lact. salivarius
6 Lact. reuteri Lact. reuteri
Lact. casei
7 Lact. reuteri (3) Lact. reuteri
Strep. salivarius
8 Step. sanguinis Lact. reuteri (2)
9 L. lactis ssp. lactis (2) Strep. salivarius
10 Strep. sanguinis Strep. sanguinis Strep. sanguinis
11 Strep. salivarius (2) Strep. salivarius (2) Lact. reuteri( 3 )
12 Strep. salivarius Strep. salivarius (3) Strep. salivarius
Lact. reuteri (2)
13 Strep. salivarius (2) Strep. salivarius
aThe number in parenthesis is the number of isolates if more than one.
3. Results
3.1. The Health Status of the Gastroscopy Patients. None of
the patients recruited in the study proved to have H. pylori
infection or any other obvious disturbance aﬀecting the
status of the gastric mucosa or the normal conditions of the
stomach.
3.2. The Bacterial Counts in the Enriched Samples. As can
be seen in Table 1, high CFU counts of cultivable bacteria,
typically around log 8mL−1, were obtained during the
enrichment. Without this step the CFU counts were typically
near or below the detection limit of the plate counting
(Table 2). However, even with enrichment, the bacterial
numbers obtained from the same patient could vary consid-
erably depending on the gastric location. For example, the
biopsies from the antrum of patients 3 and 9 and the biopsy
from the cardia of patient 3 showed no bacterial growth on
some all or the media used, although the enrichment was
applied. While in many cases the plate counts on Wilkins-
Chalgren agar were several orders of magnitude lower than
those on Plate count or MRS agar this was not universal. The
counts on MRS tended to be rather close to those seen on
Plate Count agar.
3.3. The Species Distribution of the LAB Recovered from MRS
Plates. The colonies on MRS plates typically represented
morphologically one to three dominant types. These were
further characterised and the species distribution, as indi-
cated by the 16S rDNA sequence is given in Table 3.I tc a n
be seen that the majority of the recovered isolates were
identiﬁed as Streptococcus salivarius or Strep. sanguis while
the typical lactobacilli were Lactobacillus reuteri and Lact.
salivarius. A single isolate of Lact. casei was also encountered.4 ISRN Gastroenterology
With the Strep. salivarius isolates the species indicated by
the 16S rDNA sequence was actually the very closely related
Strep. thermophilus, but since all the isolates were galactose-
fermenting it was concluded that Strep. thermophilus is a
more likely identiﬁcation.
4. Discussion
The PMEU technology has been previously successfully
applied to enrich microorganisms from samples where their
numbers are low [10–12] and the present study shows that
the approach can be applied also to clinical specimen and
that LAB, mainly streptococci and few lactobacilli, can be
enriched from gastric biopsies. This species distribution dif-
fersfromthetypicalintestinalLABmicrobiotadominatedby
enterococci and a wide variety of lactobacilli [13]. Since the
gastroscopy patients had fasted overnight, it is unlikely that
the bacteria recovered represent transient food-associated
microorganisms, but represent species of salivary origin.
This is supported by the presence of Strep. salivarius and
Strep. sanguis, which are normal oral bacteria and probably
carried to stomach via ingestion. Also the possibility that the
enrichment step selected certain species, thus creating bias in
the species distribution, cannot be excluded.
On the basis of the limited data it cannot be stated,
whether there is any preference for the bacterial presence
regarding the diﬀerent parts of the stomach (cardia, antrum,
or pylorus).
Without the enrichment step the recovered bacterial
counts were low, occasionally below the detection limit,
indicating that cultivable mucosa-associated bacteria are
rare, as can be expected. However, they can be found at least
after the enrichment, and the question arises, whether they,
including the ones originally ingested with food or saliva,
represent some type of adaptation to gastric conditions.
Since the focus of this study was on LAB, the colonies from
Plate Count or Wilkins-Chalgren plates were not analysed
further. These media were included to get an idea of the total
amount of bacteria in the enrichment broth and whether
there is some variability in the species composition that
is reﬂected on diﬀerential growth on one of these media.
The fact that the CFU counts on Wilkins-Chalgren medium
were often (but not always) lower than on other media may
indicate species diﬀerences between diﬀerent individuals,
particularly among anaerobes.
Gastric environment is a challenge regarding the pos-
sibilities of probiotic therapy. For example, although some
indication of beneﬁcial eﬀects of probiotics on Helicobacter
pylori have been detected [14], the standard probiotic
strains, being of faecal origin, probably are not optimal
regarding the gastric or duodenal conditions. Strains derived
from that region could have advantages in this respect.
Additionally, gastric strains could also be useful because of
their improved survival during the gastrointestinal passage,
as already indicated in introduction.
Withaproperdesignoftheenrichmentconditions(com-
position and the pH of the medium) potential probiotic can-
didates could be isolated also from the gastric environment.
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